Duration of untreated Chlamydial genital infection and factors associated with clearance: Review of animal studies

Journal of Infectious Diseases

Volumn 201, Issue SUPPL. 2, 2010, Pages

  Miyairi, Isao ^a   Ramsey, Kyle H ^a,b,c   Patton, Dorothy L ^a,b,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; ESTRADIOL; GAMMA INTERFERON;

ADAPTIVE IMMUNITY; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; EXPERIMENTAL MODEL; GENITAL TRACT INFECTION; GUINEA PIG; HUMAN; INNATE IMMUNITY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; REVIEW; SHEEP; SWINE; TH1 CELL; ANIMAL; DISEASE MODEL; FEMALE; GYNECOLOGIC DISEASE; IMMUNOLOGY; MICROBIOLOGY; PATHOPHYSIOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CHLAMYDIA TRACHOMATIS; DISEASE MODELS, ANIMAL; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; IMMUNITY, INNATE;

EID: 77953111064     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652393     Document Type: Review

References (86)

1. Centers for Disease Control and Prevention. Chlamydia Prevalence Monitoring Project annual report 2007: sexually transmitted disease surveillance 2007 supplement. Atlanta, GA: Centers for Disease Control and Prevention, 2009.
2. Global prevalence and incidence of selected curable sexually transmitted infections. Geneva, Switzerland: World Health Organization, 2001.
3. Molano M, Meijer CJ, Weiderpass E, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis 2005; 191:907-916.
4. Geisler W. Duration of untreated uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J Infect Dis 2010; 201 (suppl 2):S104-S113 (in this supplement).
5. Mount DT, Bigazzi PE, Barron AL. Experimental genital infection of male guinea pigs with the agent of guinea pig inclusion conjunctivitis and transmission to females. Infect Immun 1973; 8:925-930.
6. Mount DT, Bigazzi PE, Barron AL. Infection of genital tract and transmission of ocular infection to newborns by the agent of guinea pig inclusion conjunctivitis. Infect Immun 1972; 5:921-926.
7. Barron AL, White HJ, Rank RG, Soloff BL, Moses EB. A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis. J Infect Dis 1981; 143: 63-66.
8. Tuffrey M, Taylor-Robinson D. Progesterone as a key factor in the development of a mouse model for genital tract infection with Chlamydia trachomatis. FEMS Microbiol Lett 1981; 12:111-115. (Pubitemid 12243441)
9. Patton DL, Rank RG. Animal models for the study of pelvic inflammatory diseases. In: Quinn TC, ed. Sexually transmitted diseases. New York: Raven Press, 1992:85-111.
10. Rank RG, Whittum-Hudson J. Protective immunity to Chlamydia: evidence from animal studies. J Infect Dis 2010; 201(suppl 2):S168-S177 (in this supplement).
11. Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect Immun 2002; 70:2741-2751. (Pubitemid 34564127)
12. Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 2005; 5: 149-161.
13. Bavoil PM, Wyrick PB, eds. Chlamydia genomics and pathogenesis. Wymondham, United Kingdom: Horizon Bioscience, 2006.
14. Roan NR, Starnbach MN. Immune-mediated control of Chlamydia infection. Cell Microbiol 2008; 10:9-19.
15. Rank RG. Chlamydial diseases. In: Fox Jea, ed. The mouse in biomedical research. 2nd ed. Vol 2. San Diego, CA: Elsevier, 2007:325-348.
16. Janowicz DM, Ofner S, Katz BP, Spinola SM. Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience. J Infect Dis 2009; 199:1671-1679.
17. Cohen MS, Cannon JG. Human experimentation with Neisseria gonorrhoeae: progress and goals. J Infect Dis 1999; 179(suppl 2):S375-S379.
18. Vanrompay D, Lyons JM, Morre SA. Animal models for the study of Chlamydia trachomatis infections in the female genital infection. Drugs Today (Barc) 2006; 42(suppl A):55-63.
19. Papp JR, Shewen PE. Chlamydia psittaci infection in sheep: a paradigm for human reproductive tract infection. J Reprod Immunol 1997; 34: 185-202.
20. Patton DL, Halbert SA, Kuo CC, Wang SP, Holmes KK. Host response to primary Chlamydia trachomatis infection of the fallopian tube in pigtailed monkeys. Fertil Steril 1983; 40:829-840.
21. Patton DL, Kuo CC, Wang SP, et al. Chlamydial infection of subcutaneous fimbrial transplants in cynomolgus and rhesus monkeys. J Infect Dis 1987; 155:229-235.
22. Cotter TW, Miranpuri GS, Ramsey KH, Poulsen CE, Byrne GI. Reactivation of chlamydial genital tract infection in mice. Infect Immun 1997; 65:2067-2073. (Pubitemid 27237279)
23. de la Maza LM, Pal S, Khamesipour A, Peterson EM. Intravaginal in oculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun 1994; 62:2094-2097.
24. Shah AA, Schripsema JH, Imtiaz MT, et al. Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex Transm Dis 2005; 32:49-56.
25. Darville T, Andrews CW Jr, Laffoon KK, Shymasani W, Kishen LR, Rank RG. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect Immun 1997; 65:3065-3073. (Pubitemid 27342379)
26. Bernstein-Hanley I, Coers J, Balsara ZR, Taylor GA, Starnbach MN, Dietrich WF. The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice. Proc Natl Acad Sci USA 2006; 103:14092-14097.
27. Min-Oo G, Lindqvist L, Vaglenov A, et al. Genetic control of susceptibility to pulmonary infection with Chlamydia pneumoniaein the mouse. Genes Immun 2008; 9:383-388.
28. Miyairi I, Tatireddigari VR, Mahdi OS, et al. The p47 GTPases Iigp2 and Irgb10 regulate innate immunity and inflammation to murine Chlamydia psittaciinfection. J Immunol 2007; 179:1814-1824.
29. Pal S, Peterson EM., de la Maza LM. New murine model for the study of Chlamydia trachomatis genitourinary tract infections in males. Infect Immun 2004; 72:4210-4216.
30. Morrison SG, Morrison RP. In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection. Infect Immun 2000; 68:2870-2879.
31. Rank RG, Soderberg LS, Barron AL. Chronic chlamydial genital infection in congenitally athymic nude mice. Infect Immun 1985; 48:847-849. (Pubitemid 15227244)
32. Cotter TW, Ramsey KH, Miranpuri GS, Poulsen CE, Byrne GI. Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun 1997; 65:2145-2152.
33. Perry LL, Feilzer K, Caldwell HD. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J Immunol 1997;158:3344-3352.
34. Morrison RP, Feilzer K, Tumas DB. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 1995; 63:4661-4668.
35. Rank RG, Ramsey KH, Pack EA, Williams DM. Effect of gamma interferon on resolution of murine chlamydial genital infection. Infect Immun 1992; 60:4427-4429.
36. Igietseme JU, Ramsey KH, Magee DM, Williams DM, Kincy TJ, Rank RG. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg Immunol 1993; 5: 317-324.
37. Kelly KA, Rank RG. Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect Immun 1997; 65:5198-5208.
38. Hawkins RA, Rank RG, Kelly KA. Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo. Infect Immun 2000; 68: 5587-5594.
39. Ramsey KH, Soderberg LS, Rank RG. Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect Immun 1988; 56:1320-1325.
40. Johansson M, Ward M, Lycke N. B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis. Immunology 1997; 92:422-1128 (Pubitemid 27525212)
41. Igietseme JU, Magee DM, Williams DM, Rank RG. Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones. Infect Immun 1994; 62:5195-5197.
42. Roan NR, Starnbach MN. Antigen-specific CD8+ T cells respond to Chlamydia trachomatis in the genital mucosa. J Immunol 2006; 177: 7974-7979.
43. Barteneva N, Theodor I, Peterson EM, de la Maza LM. Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection. Infect Immun 1996; 64:4830-4833.
44. Tseng CT, Rank RG. Role of NK cells in early host response to chlamydial genital infection. Infect Immun 1998; 66:5867-5875.
45. Ito JI, Lyons JM. Role of gamma interferon in controlling murine chlamydial genital tract infection. Infect Immun 1999; 67:5518-5521. (Pubitemid 29455338)
46. Nelson DE, Virok DP, Wood H, et al. Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc Natl Acad Sci USA 2005; 102:10658-10663. (Pubitemid 41061610)
47. Coers J, Bernstein-Hanley I, Grotsky D, et al. Chlamydia muridarumevades growth restriction by the IFN-gamma-inducible host resistance factor Irgb10. J Immunol 2008; 180:6237-6245.
48. Perry LL, Su H, Feilzer K, et al. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. J Immunol 1999; 162:3541-3548.
49. Tuffrey M, Falder P, Taylor-Robinson D. Genital-tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis. Br J Exp Pathol 1982; 63: 539-539-546. (Pubitemid 13250649)
50. Johansson M., Schon K, Ward M, Lycke N. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect Immun 1997; 65:1032-1044.
51. Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994; 58:686-699. (Pubitemid 124005209)
52. Wyrick PB. Chlamydia trachomatis persistence in vitro: an overview. J Infect Dis 2010; 201(suppl 2):S88-S95 (in this supplement).
53. Ramsey KH, Miranpuri GS, Poulsen CE, Marthakis NB, Braune LM, Byrne GI. Inducible nitric oxide synthase does not affect resolution of murine chlamydial genital tract infections or eradication of chlamydiae in primary murine cell culture. Infect Immun 1998; 66:835-838.
54. Ramsey KH, Miranpuri GS, Sigar IM, Ouellette S, Byrne GI. Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect Immun 2001; 69:5131-5137.
55. Murray ES. Guinea pig inclusion conjunctivitis virus. I. Isolation and identification as a member of the psittacosis-lymphogranuloma-trachoma group. J Infect Dis 1964; 114:1-12.
56. Rank RG, Bowlin AK, Reed RL, Darville T. Characterization of chlamydial genital infection resulting from sexual transmission from male to female guinea pigs and determination of infectious dose. Infect Immun 2003; 71:6148-6154. (Pubitemid 37337668)
57. Rank RG, Sanders MM. Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection. Am J Pathol 1992; 140:927-936.
58. Rank RG, White HJ, Hough AJ Jr, Pasley JN, Barron AL. Effect of estradiol on chlamydial genital infection of female guinea pigs. Infect Immun 1982; 38:699-705.
59. Rank RG, Sanders MM, Kidd AT. Influence of the estrous cycle on the development of upper genital tract pathology as a result of chlamydial infection in the guinea pig model of pelvic inflammatory disease. Am J Pathol 1993; 142:1291-1296.
60. Barron AL, White HJ, Rank RG, Soloff BL. Target tissues associated with genital infection of female guinea pigs by the chlamydial agent of guinea pig inclusion conjunctivitis. J Infect Dis 1979; 139:60-68.
61. Rank RG, Barron AL. Effect of antithymocyte serum on the course of chlamydial genital infection in female guinea pigs. Infect Immun 1983; 41:876-879. (Pubitemid 13074657)
62. Rank RG, Bowlin AK, Kelly KA. Characterization of lymphocyte response in the female genital tract during ascending chlamydial genital infection in the guinea pig model. Infect Immun 2000; 68:5293-5298.
63. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL. Analysis of lymphocyte phenotype and cytokine activity in the inflammatory infiltrates of the upper genital tract of female macaques infected with Chlamydia trachomatis. J Infect Dis 1996; 174:647-650.
64. Ficarra M, Ibana JS, Poretta C, et al. A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection. Am J Reprod Immunol 2008; 60:415-1125
65. Rank RG, White HJ, Barron AL. Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 1979; 26:573-579.
66. Rank RG, Barron AL. Specific effect of estradiol on the genital mucosal antibody response in chlamydial ocular and genital infections. Infect Immun 1987; 55:2317-2319.
67. Ripa KT, Moller BR, Mardh PA, Freundt EA, Melsen F. Experimental acute salpingitis in grivet monkeys provoked by Chlamydia trachomatis. Acta Pathol Microbiol Scand B 1979; 87B:65-70.
68. Moller BR, Mardh PA. Experimental epididymitis and urethritis in grivet monkeys provoked by Chlamydia trachomatis. Fertil Steril 1980; 34: 275-279.
69. Johnson AP, Hare MJ, Wilbanks GD, et al. A colposcopic and histological study of experimental chlamydial cervicitis in marmosets. Br J Exp Pathol 1984; 65:59-65.
70. Wolner-Hanssen P, Patton DL, Holmes KK. Protective immunity in pigtailed macaques after cervical infection with Chlamydia trachomatis. Sex Transm Dis 1991; 18:21-25.
71. Patton DL. Immunopathology and histopathology of experimental chlamydial salpingitis. Rev Infect Dis 1985; 7:746-753.
72. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun 1997; 65:2175-2182.
73. Lichtenwalner AB, Patton DL, Cosgrove Sweeney YT, Gaur LK, Stamm WE. Evidence of genetic susceptibility to Chlamydia trachomatis-induced pelvic inflammatory disease in the pig-tailed macaque. Infect Immun 1997; 65:2250-2253.
74. Vanrompay D, Hoang TQ, De Vos L, et al. Specifie-pathogen-free pigs as an animal model for studying Chlamydia trachomatis genital infection. Infect Immun 2005; 73:8317-8321.
75. Pospischil A, Borel N, Chowdhury EH, Guscetti F. Aberrant chlamydial developmental forms in the gastrointestinal tract of pigs spontaneously and experimentally infected with Chlamydia suis. Vet Microbiol 2008; 35:147-156.
76. Louv WC, Austin H, Perlman J, Alexander WJ. Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol 1989; 160:396-1102
77. Maslow AS, Davis CH, Choong J, Wyrick PB. Estrogen enhances attachment of Chlamydia trachomatis to human endometrial epithelial cells in vitro. Am J Obstet Gynecol 1988; 159:1006-1014.
78. Guseva NV, Knight ST, Whittimore JD, Wyrick PB. Primary cultures of female swine genital epithelial cells in vitro: a new approach for the study of hormonal modulation of Chlamydia infection. Infect Immun 2003; 71:4700-4710.
79. Papp JR, Shewen PE. Localization of chronic Chlamydia psittaci infection in the reproductive tract of sheep. J Infect Dis 1996; 174:1296-1302.
80. Agrawal T, Vats V, Salhan S, Mittal A. Determination of chlamydial load and immune parameters in asymptomatic, symptomatic and infertile women. FEMS Immunol Med Microbiol 2009; 55:250-257.
81. Coers J, Starnbach MN, Howard JC. Modeling infectious disease in mice: co-adaptation and the role of host-specific IFNgamma responses. PLoS Pathog 2009; 5:e1000333.
82. Goulder PJ, Watkins DI. Impact of MHC dass I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2008; 8: 619-630.
83. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol 2007; 7:118-130. (Pubitemid 46174859)
84. Ku CC, Zerboni L, Ito H, Graham BS, Wallace M, Arvin AM. Varicellazoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med 2004; 200:917-925. (Pubitemid 39362927)
85. Su H, Morrison R, Messer R, Whitmire W, Hughes S, Caldwell HD. The effect of doxycydine treatment on the development of protective immunity in a murine model of chlamydial genital infection. J Infect Dis 1999; 180:1252-1258. (Pubitemid 30070211)
86. Brunham RC, Rekart ML. The arrested immunity hypothesis and the epidemiology of chlamydia control. Sex Transm Dis 2008; 35:53-54.